Dawn Averitt

Learn More
OBJECTIVES To compare the lipid and metabolic effects, efficacy, and safety of twice-daily regimens of Trizivir (abacavir 300 mg/lamivudine 150 mg/zidovudine 300 mg triple nucleoside tablet; TZV), Combivir (lamivudine 150 mg/zidovudine 300 mg combination tablet; COM)+nelfinavir (NFV), and stavudine (d4 T)+lamivudine (3TC)+NFV. STUDY DESIGN An(More)
Research focusing on rebuilding the immune system and keeping HIV infection under control over the long term is reported. The research involves increasing immune cells, rebuilding the tissues that produce new cells, boosting the immune response, and protecting new and existing cells from infection. An overview of how HIV affects the immune system is(More)